{"id":"W2885345548","doi":"10.1007/s10637-018-0627-4","title":"Characterization and phase I study of CLR457, an orally bioavailable pan-class I PI3-kinase inhibitor","year":2018,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Novartis Pharmaceuticals Corporation","keywords":"Rash; Medicine; Pharmacokinetics; Toxicity; Pharmacology; Bioavailability; Adverse effect; In vivo; Mucositis; Population; Internal medicine; Gastroenterology; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008601906,0.0007555769,0.00107902,0.0003134335,0.0002043755,0.0008852248,0.0006716198,0.0005648484,0.001292039],"category_scores_gemma":[0.0003908011,0.0003762884,0.0005146759,0.0003445666,0.0003700324,0.0004091316,0.0002037813,0.001508134,0.0005655821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007364833,"about_ca_system_score_gemma":0.001083391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009007857,"about_ca_topic_score_gemma":0.001875264,"domain_scores_codex":[0.9996324,0.0001287857,0.00002302346,0.00007469554,0.00006537256,0.00007571642],"domain_scores_gemma":[0.9997489,0.00002388072,0.00006214558,0.00003351713,0.00002964111,0.0001019696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.02821849,0.02782873,0.00698641,0.0007528887,0.0007140482,0.0005030683,0.0002435244,0.006905967,0.8348512,0.0006993486,0.004172021,0.08812439],"study_design_scores_gemma":[0.0565162,0.5729554,0.03866342,0.00008149179,0.00141482,0.003138878,0.0002329036,0.01563436,0.2828975,0.0006751785,0.02768059,0.0001093267],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909773,0.002726469,0.002403866,0.0002330844,0.00004139154,0.001112944,0.0009305742,0.0001348233,0.001439552],"genre_scores_gemma":[0.989143,0.001716646,0.002793459,0.0004545334,0.00004017293,0.0006803653,0.003326527,0.00005146676,0.001793683],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001292039,"threshold_uncertainty_score":0.005343616,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02063008807820533,"score_gpt":0.2880444537127292,"score_spread":0.2674143656345239,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}